# OnCo record patricia (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/patricia/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "patricia", "NCT00122681" ;
  schema:name "PATRICIA"@en ;
  schema:alternateName "HPV-008"@en, "HPV 008"@en, "PApilloma TRIal against Cancer In young Adults"@en, "580299/008"@en ;
  schema:description "PATRICIA showed that three doses of a vaccine against the two human papillomavirus types behind most cervical cancers prevented almost all of the type-specific high-grade cervical precancers in young women who were free of those types when vaccinated, which carried Cervarix to approval in Europe and the United States."@en ;
  schema:url <https://onco.cc/trials/patricia/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00122681>, <https://doi.org/10.1016/S0140-6736(09)61248-4>, <https://www.ema.europa.eu/en/medicines/human/EPAR/cervarix> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/hpv-bivalent-vaccine/> ;
  onco:companies <https://onco.cc/companies/gsk/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-patricia-paavonen-lancet-2009/> .